We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Online Platform Improves Proton Therapy Delivery

By MedImaging International staff writers
Posted on 03 Nov 2021
Print article
Image: The Proteus PLUS proton therapy solution (Photo courtesy of IBA)
Image: The Proteus PLUS proton therapy solution (Photo courtesy of IBA)
A new interactive platform enables proton therapy providers to share materials and resources, as well as discussion forums with other users.

Ion Beam Applications (IBA; Louvain-La-Neuve, Belgium) Campus is dedicated to help clinicians and researchers in proton therapy enhance existing and learn new skills for the benefit of patients. Campus visitors will also have access to IBA’s network of proton therapy experts, who have deep knowledge and experience in working with the IBA state-of-the-art Proteus systems. Campus was presented at the annual American Society for Radiation Oncology (ASTRO) meeting, held during October 2021 in Chicago (IL, USA).

The IBA Proteus ONE is a single-room configuration consisting of an accelerator, a direct beam line, and a compact gantry. It is equipped with cone beam CT (CBCT), stereoscopic imaging, and pencil beam scanning (PBS) technologies, which allow the treatment of a diverse range of ocular tumors, central nervous system (CNS) cancers, head and neck malignancies, thoracic tumors, and abdominal and pelvic malignancies. IBA also offers Proteus PLUS, a made-to-measure, image-guided, intensity-modulated, proton beam technology system.

“An online platform dedicated solely to proton therapy will allow users to access and utilize resources at the click of a button,” said Professor Hans Langendijk, MD, PhD, of UMC Groningen (The Netherlands). “I am excited to learn from IBA’s network of leading experts, as they share their latest findings, with the ultimate goal of improving not only the quality of patient treatment but also the general operations behind our proton therapy centers.”

“Campus will be an invaluable tool to those working within the proton therapy field, particularly those starting out their careers in this dynamic area,” said Professor James Metz, MD, chair of the department of radiation oncology at Penn Medicine (Philadelphia, PA, USA). “Access to educational materials, focused events, and support from IBA’s network of experienced operating centers will be key in allowing users to learn and assist in the advancement of this important technology.”

Proton therapy is a precise form of radiotherapy (RT) that uses charged particles instead of x-rays. It can be a more effective form of treatment than conventional radiotherapy, as it directs RT more precisely, with minimal damage to surrounding tissue. Evidence is growing that protons can be effective in treating a number of cancers, in particular children and young people with brain tumors, for whom it appears to produce fewer side effects such as secondary cancers, growth deformity, hearing loss, and learning difficulties.

Related Links:
Ion Beam Applications

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
Mobile Digital C-arm X-Ray System
HHMC-200D
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article
Radcal

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.